CINXE.COM
Schr枚dinger and Novartis Forge Partnership to Scale Computational Drug Discovery
<!DOCTYPE html> <html lang="en"> <head> <meta charset="UTF-8"> <title> Schr枚dinger and Novartis Forge Partnership to Scale Computational Drug Discovery </title> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <link rel="canonical" href="https://www.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/" /> <!-- Google tag (gtag.js) --> <script async src="https://www.googletagmanager.com/gtag/js?id=G-YK7FCK71TD"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-YK7FCK71TD'); </script> <meta name="description" content="" /> <meta name="keywords" content="" /> <!-- Twitter Card data --> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:title" content="Schr枚dinger and Novartis Forge Partnership to Scale Computational Drug Discovery"> <meta name="twitter:description" content=""> <meta name="twitter:image" content="https://www.biopharmatrend.com/files/blog/social/iStock-2156655252.jpg"> <!-- Open Graph data --> <meta property="og:type" content="article" /> <meta property="og:url" content="https://www.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/" /> <meta property="og:title" content="Schr枚dinger and Novartis Forge Partnership to Scale Computational Drug Discovery" /> <meta property="og:description" content="" /> <meta property="article:published_time" content="2024-11-12T21:56:33+00:00"> <meta property="article:modified_time" content="2024-11-12T21:56:33+00:00"> <meta name="author" content="Roman Kasianov"> <meta property="og:image" content="https://www.biopharmatrend.com/files/blog/social/iStock-2156655252.jpg"> <script type="application/ld+json">{ "@context": "https://schema.org", "@type": "NewsArticle", "headline": "Schr\u00f6dinger and Novartis Forge Partnership to Scale Computational Drug Discovery", "datePublished": "2024-11-12T21:56:33+00:00", "dateModified": "2024-11-12T21:56:33+00:00", "description": "Schr\u00f6dinger, Inc.\n(Nasdaq: SDGR)\nhas entered a collaboration\nand licensing agreement with\nNovartis\nto advance drug discovery efforts on multiple targets. This collaboration involves a $150 million upfront payment from Novartis to Schr\u00f6dinger,\nwith eligibility for up to $2.3 billion in research\n, regulatory, and commercial milestone payments, as well as tiered royalties on net sales of resulting products.", "image": "https://www.biopharmatrend.com/files/blog/social/iStock-2156655252.jpg", "url": "https://www.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/" }, "publisher": { "@type": "Organization", "name": "BiopharmaTrend", "url": "https://www.biopharmatrend.com", "logo": { "@type": "ImageObject", "url": "https://www.biopharmatrend.com/static/img/bpt_logo.png" } }, "author": [ { "@type": "Person", "name": "Roman Kasianov", "url": "https://www.biopharmatrend.com/contributor/743/" } ] }</script> <style type="text/css"> .ap-chart-load svg { width: 100%; } .post-meta .author-linkein-icon { width: 1em; vertical-align: baseline; } .text-miniblock { display: inline-block; box-shadow: 0 0 6px -1px forestgreen; background: white; padding: 0.5rem; } .post .text-miniblock a { color: black; } .post .text-miniblock a:hover, .post .text-miniblock a:active { color: #333; text-decoration: underline; } .text-miniblock-right { float: right; margin: 0 0 1rem 1rem; max-width: 14rem; } .subscribe-block { background-color: deepskyblue; color: white; margin-top: 1.5rem; margin-bottom: 2rem; padding-top: 1.5rem; padding-bottom: 1.5rem; width: calc(50% + 100vw); padding-left: calc(50vw - 50%); padding-right: 50vw; margin-left: calc(50% - 50vw); position: relative; } .subscribe-block > .subscribe-inner { background-image: url('/files/subscription-bg.png'); background-position: right bottom; background-size: auto 120%; background-repeat: no-repeat; } .mobile-only { display: none; } @media screen and (max-width: 34em) { .text-miniblock-right { float: none; margin: 1rem 0; max-width: 100%; } .subscribe-block > .subscribe-inner { background-image: unset; } .mobile-only { display: block; } } </style> <link rel="shortcut icon" href="/static/favicon.ab1145f4d518.ico" /> <link rel="stylesheet" type="text/css" href="/static/css/main.6dead4e2266d.css" /> </head> <body> <div id="main-preheader"> <div class="container block-preheader"> <div id="logo-top"> <a href="/"><b>BioPharmaTrend</b></a> <!-- <a href="/"><img src="/files/bpt_logo2.svg" alt="BioPharmaTrend" style="max-height: 1em;" /></a> --> </div> <div class="burger-container"> <div class="burger-button-container"> <button type="button" class="burger-button" onclick="document.documentElement.classList.toggle('blockfix');this.parentElement.parentElement.classList.toggle('active');"> <div class="burger-line burger-line-1"></div> <div class="burger-line burger-line-2"></div> <div class="burger-line burger-line-3"></div> </button> </div> <!-- Search block --> <div id="main-search-menu"> <div class="top-search"> <form action="/search/" class="top-search-form"> <button type="submit" class="btn btn-default"><i class="glyphicon glyphicon-search"></i></button> <input type="text" name="q" value="" size="10" class="form-control form-control-inline" required="" placeholder="e.g. 'quantum tech' or 'stem cell'"> <input type="hidden" name="section" value="insights"> </form> <span class="top-search-switcher button" onclick="this.parentElement.classList.toggle('active')"> <span class="glyphicon glyphicon-search"></span> <span class="glyphicon glyphicon-remove"></span> </span> </div> <span class="top-search-switcher button"> <span class="glyphicon glyphicon-search"></span> </span> </div> <!-- Main Menu block --> <nav id="main-menu"> <div class="mobile-menu-item"> <a class="top-menu-link mobile-menu-item-title" href="/section/news/"><b>Latest News</b></a> </div> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">All Topics <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <li><a class="top-menu-link" href="/topic/bioeconomy-society/">Bioeconomy & Society</a></li> <li><a class="top-menu-link" href="/topic/ai-digital/">AI & Digital</a></li> <li><a class="top-menu-link" href="/topic/startups/">Startups & Deals</a></li> <li><a class="top-menu-link" href="/topic/neurotech/">NeuroTech</a></li> <li><a class="top-menu-link" href="/topic/clinical-trials/">Clinical Trials</a></li> <li><a class="top-menu-link" href="/topic/synbio/">Biotech</a></li> <li><a class="top-menu-link" href="/topic/tools-methods/">Tools & Methods</a></li> <li><a class="top-menu-link" href="/topic/healthtech/">HealthTech</a></li> <li><a class="top-menu-link" href="/topic/aging-research/">Aging & Longevity</a></li> <li><a class="top-menu-link" href="/topic/contract-research/">Contract Research</a></li> <div class="sub-menu-margin"></div> <!--<li><a class="top-menu-link" href="/ai-drug-discovery-pipeline/">Historical Pipeline Analysis</a></li> --> <li><a class="top-menu-link" href="/section/latest/">Latest insights</a></li> <li><a class="top-menu-link" href="/premium-content/">Premium Content</a></li> <div class="sub-menu-margin" style="border-bottom: 1px solid limegreen;"></div> <li><a class="top-menu-link" href="/knowledge-center/">Knowledge Center</a></li> </ul> </div> </div> <div class="mobile-menu-item"> <a class="top-menu-link mobile-menu-item-title" href="/section/interviews/"><b>Interviews</b></a> </div> <!-- <div class="mobile-menu-item"> <b class="mobile-menu-item-title">Library</b> </div> --> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">Companies <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <!-- <li><a class="top-menu-link" href="/post/789-a-landscape-of-ai-discovered-molecules-and-target-novelty-analysis/">AI Pipeline Analysis</a></li> --> <li><a class="top-menu-link" href="/m/marketplace/">Company Directory</a></li> <li><a class="top-menu-link" href="/section/interviews/">Interviews with Thought Leaders</a></li> <li><a class="top-menu-link" href="/section/case-studies/">Sponsored Case Studies</a></li> <li><a class="top-menu-link" href="/m/editor-tool/">Create Company Profile</a></li> </ul> </div> </div> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">More <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <li><a class="top-menu-link" href="/about/">About Us</a></li> <li><a class="top-menu-link" href="/about/team/">Our Team</a></li> <li><a class="top-menu-link" href="/about/advisory-board/">Advisory Board</a></li> <li><a class="top-menu-link" href="/about/press-citations/">Citations and Press Coverage</a></li> <li><a class="top-menu-link" href="/events/">Partner Events Calendar</a></li> <li><a class="top-menu-link" href="/advertising-media-kit/">Advertise with Us</a></li> <li><a class="top-menu-link" href="/contributor/">Write for Us</a></li> </ul> </div> </div> </nav> </div> <div id="main-user-actions"> <!-- Subscribe block --> <div class="mobile-menu-item"> <a href="/membership/" class="button-subscribe top-menu-link">Subscribe</a> </div> <!-- User menu --> <div class="mobile-menu-item last"> <a href="#" class="mobile-menu-item-title" rel="nofollow" title="Login/Join" onclick="document.getElementById('login-popup').classList.toggle('hidden')"> <span class="glyphicon glyphicon-log-in"></span> <span class="mobile-hide-m">Login/Join</span> </a> </div> </div> </div> </div> <div id="main-preheader-margin"></div> <div id="sencondary-menu-block"> <div class="container clearfix"> <nav> <ul class="text-center"> <li><a href="/topic/ai-digital/">AI & Digital</a></li> <li><a href="/topic/startups/">Startups & Deals</a></li> <li><a href="/topic/neurotech/">NeuroTech</a></li> <li><a href="/topic/clinical-trials/">Clinical Trials</a></li> <li><a href="/topic/synbio/">Biotech</a></li> <li><a href="/topic/tools-methods/">Tools & Methods</a></li> </ul> </nav> </div> </div> <!-- <header id="main-header" class="brand-block"> <div class="container clearfix"> </div> </header> --> <div id="main-content" class="container"> <main id="content" class="col-lg-9 col-md-8 col-sm-12 col-xs-12"> <div class="mobile-only"> </div> <article id="post-1020" class="post "> <header> <h1>Schr枚dinger and Novartis Forge Partnership to Scale Computational Drug Discovery</h1> </header> <footer class="post-meta"> <div class="tooltip"> <span class="glyphicon glyphicon-pencil"></span> by <a href="/contributor/743/">Roman Kasianov</a> </span> <span style="white-space: nowrap;"> <span class="glyphicon glyphicon-folder-open"></span> News </span> <div class="tooltip-text"> <div class="tooltip-close" onclick="this.parentElement.parentElement.classList.toggle('tooltip-show');"></div> <p><b>Disclaimer</b>: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. <br> Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.</p> </div> </div> <div> <span class="glyphicon glyphicon-calendar" title="Published on"></span> <time datetime="2024-11-12">Nov. 12, 2024</time> </em> </div> <div class="tags"> <b>Topics: </b> <a href="/topic/startups/">Startups & Deals</a> </div> <div> <strong>Share: </strong> <a target="_blank" rel="nofollow" href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/"> <img alt="Share in LinkedIn" src="/static/img/soc-in.7bc286fd757e.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.reddit.com/submit?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/"> <img alt="Share in Reddit" src="/static/img/soc-reddit.342e87a07115.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/"> <img alt="Share in X" src="/static/img/soc-x.3c80e8291cba.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://news.ycombinator.com/submitlink?u=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/"> <img alt="Share in Hacker News" src="/static/img/soc-y.587f16a5f3f3.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/&display=page"> <img alt="Share in Facebook" src="/static/img/soc-fb.3031a5a810f0.png" width="28" height="28" /></a> <a target="_blank" rel="nofollow" href="mailto:?subject=Biopharmatrend.com&body=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/"> <img alt="Send by email" src="/static/img/soc-mail.41ce3608f438.png" width="28" height="28"></a> | <a href="/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/pdf/" target="_blank" rel="nofollow"> <span style="vertical-align: text-top; color: deepskyblue; font-size: 1.5em;" class="glyphicon glyphicon-print"></span></a> </div> </footer> <section> <p><a href="https://ir.schrodinger.com">Schrödinger, Inc.</a> (Nasdaq: SDGR) <a href="https://ir.schrodinger.com/press-releases/news-details/2024/Schrdinger-Announces-Multi-Target-Collaboration-and-Expanded-Software-Licensing-Agreement-with-Novartis/default.aspx?utm_content=316103262&utm_medium=social&utm_source=linkedin&hss_channel=lcp-35342">has entered a collaboration</a> and licensing agreement with <a href="https://www.novartis.com/">Novartis</a> to advance drug discovery efforts on multiple targets. This collaboration involves a $150 million upfront payment from Novartis to Schrödinger, <strong>with eligibility for up to $2.3 billion in research</strong>, regulatory, and commercial milestone payments, as well as tiered royalties on net sales of resulting products.</p> <p>The partnership includes a three-year software licensing expansion, enabling Novartis to leverage Schrödinger's computational drug discovery platform at scale. This platform, supported by Schrödinger’s predictive modeling and informatics technology, will integrate deeply into Novartis’s global research operations to drive a computational-first approach to drug discovery.</p> <p>The collaboration will focus on advancing candidates for Novartis’s therapeutic areas, with joint responsibility in discovery stages. Novartis will handle clinical development, manufacturing, and commercialization. Full integration of Schrödinger’s software across Novartis’s research units is anticipated to enhance Novartis’s research efficiency and innovation pace.</p> <p>Schrödinger CEO Ramy Farid, Ph.D., and Novartis Biomedical Research President Fiona Marshall highlighted the strategic benefits of the collaboration in driving forward computational approaches in drug development. Schrödinger’s platform, built over 30 years, supports a portfolio that includes collaborative projects and clinical-stage oncology programs.</p> <p>Additional terms and conditions, including regulatory clearances, apply to this agreement. Schrödinger will discuss these updates further during its Q3 financial results <a href="https://events.q4inc.com/attendee/272406226">webcast on November 12, 2024, at 8:00 a.m. ET.</a></p> <h6>Photo: <a class="photographer cWU9wH5uj9cM5CMFEMVC" data-testid="photographer" href="https://www.istockphoto.com/uk/portfolio/yuelan?mediatype=photography"><span class="LnOLJ4WPBg1pjxPKMDBE">SiyueSteuber</span></a></h6> <div class="product-list"> </div> <p> <b>Topics: </b> <a href="/topic/startups/">Startups & Deals</a> </p> </section> </article> <div style="margin: 1em 0 2em; padding: 0.5em 0;"> <strong>Share: </strong> <a target="_blank" rel="nofollow" href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/"> <img alt="Share in LinkedIn" src="/static/img/soc-in.7bc286fd757e.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.reddit.com/submit?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/"> <img alt="Share in Reddit" src="/static/img/soc-reddit.342e87a07115.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/"> <img alt="Share in X" src="/static/img/soc-x.3c80e8291cba.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://news.ycombinator.com/submitlink?u=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/"> <img alt="Share in Hacker News" src="/static/img/soc-y.587f16a5f3f3.png" width="28" height="28"></a> <a target="_blank" rel="nofollow" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/&display=page"> <img alt="Share in Facebook" src="/static/img/soc-fb.3031a5a810f0.png" width="28" height="28" /></a> <a target="_blank" rel="nofollow" href="mailto:?subject=Biopharmatrend.com&body=https%3A%2F%2Fwww.biopharmatrend.com/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/"> <img alt="Send by email" src="/static/img/soc-mail.41ce3608f438.png" width="28" height="28"></a> </div> <div class="subscribe-block"> <div class="subscribe-inner"> <h3 style="line-height:1.5; font-weight: 900;"> <span style="font-weight: 900">Get Exclusive Insights Into Your Inbox</span> <br> <span style="font-weight: normal;">join 7000+ BPT insiders</span> </h3> <br> <div> <a style="font-size: 1.25em;width:17em; text-align: center; border-color: white; color: white; font-weight: 900" href="#" onclick="toggleMailingPopup(true)" class="btn">Subscribe</a> </div> </div> </div> </main> <aside id="main-sidebar" class="col-lg-3 col-md-4 col-sm-12 col-xs-12"> <section class="well"> <h4>Latest Articles</h4> <ul> <li><a href="/post/1029-novartis-expands-radiopharmaceutical-portfolio-with-745m-deal-with-ratio-therapeutics/">Novartis Expands Radiopharmaceutical Portfolio with $745M Deal with Ratio Therapeutics</a></li> <li><a href="/post/1024-immunai-and-teva-collaborate-to-advance-clinical-trials-in-oncology-and-immunology/">Immunai and Teva Collaborate to Advance Clinical Trials in Oncology and Immunology</a></li> <li><a href="/post/1022-genesis-therapeutics-collaborates-with-nvidia-and-secures-additional-nventures-funding-to-accelerate-ai-driven-drug-discovery/">Genesis Therapeutics Collaborates with NVIDIA and Secures Additional NVentures Funding to Accelerate AI-Driven Drug Discovery</a></li> <li><a href="/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/">Schr枚dinger and Novartis Forge Partnership to Scale Computational Drug Discovery</a></li> <li><a href="/post/1016-tempus-ai-to-acquire-ambry-genetics-for-600-million/">Tempus AI to Acquire Ambry Genetics for $600 Million</a></li> <li><a href="/post/1012-uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report/">UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report</a></li> </ul> </section> </aside> </div> <footer id="main-footer"><div class="container"> <div class="row"> <div class="col-12 col-sm-6 col-lg-3"> <h4 class="footer-logo"><span style="font-weight: 900">BiopharmaTrend</span>.com</h4> <div style="margin-bottom: 1.25em" class="footer-logo-slogan">Where Tech Meets Bio</div> <!-- <p> <a style="color: #fff;border-color: #fff;" href="#main-footer" onclick="toggleMailingPopup(true)" class="btn"><b>Newsletter</b></a> </p> <p> <a href="https://www.linkedin.com/company/18118496" rel="nofollow" target="_blank"><img src="/static/img/sm-in.fb9ea368635d.png" alt="in" width="32" height="32" /></a> <a href="https://twitter.com/BiopharmaTrend" rel="nofollow" target="_blank"><img src="/static/img/sm-tw.f721ec7f127d.png" alt="tw" width="32" height="32" /></a> <a href="https://news.google.com/publications/CAAqBwgKMOaRugsw86zRAw?hl=en-US&gl=US&ceid=US:en" rel="nofollow" target="_blank"><img src="/static/img/sm-gnews.ac9eb4674c84.png" alt="gnews" width="32" height="32" /></a> <a href="/rss/" rel="nofollow" target="_blank"><img src="/static/img/sm-rss.bcd2cefd2eba.png" alt="rss" width="32" height="32" /></a> </p> --> <div style="margin-bottom: 0.5em;"><a href="#main-footer" onclick="toggleMailingPopup(true)" style="color: lemonchiffon"> <img src="/static/img/sm-mail.a3210e82fe37.png" alt="mail" width="32" height="32" /> <b>Newsletter</b> </a></div> <div style="margin-bottom: 0.5em"><a href="https://www.linkedin.com/company/biopharmatrend-com/" rel="nofollow" target="_blank"> <img src="/static/img/sm-in.fb9ea368635d.png" alt="in" width="32" height="32" /> LinkedIn </a></div> <div style="margin-bottom: 0.5em"><a href="https://twitter.com/BiopharmaTrend" rel="nofollow" target="_blank"> <img src="/static/img/sm-x.9f3327271e1a.png" alt="x" width="32" height="32" /> X </a></div> <div style="margin-bottom: 0.5em"><a href="https://news.google.com/publications/CAAqBwgKMOaRugsw86zRAw?hl=en-US&gl=US&ceid=US:en" rel="nofollow" target="_blank"> <img src="/static/img/sm-gnews.ac9eb4674c84.png" alt="gnews" width="32" height="32" /> Google News </a></div> <div><a href="/rss/" rel="nofollow" target="_blank"> <img src="/static/img/sm-rss.bcd2cefd2eba.png" alt="rss" width="32" height="32" /> RSS Feed </a></div> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>About</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/about/">What we do</a></li> <li><a href="/editorial-calendar/">Editorial Calendar</a></li> <li><a href="/about/press-citations/">Citations and Press Coverage</a></li> <li><a href="/terms-of-use/">Terms of Use</a></li> <li><a href="/privacy-policy/">Privacy Policy</a></li> <!--<li><a href="/cookies-policy/">Cookies Policy</a></li>--> <li><a href="/about/disclaimer/">Disclaimer</a></li> </ul> </nav> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>We Offer</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/premium-content/"><b style="color: lemonchiffon">Premium Content</b></a></li> <li><a href="/m/marketplace/">BioTech Scout</a></li> <li><a href="/our-products/">Reports</a></li> <li><a href="/section/interviews/">Interviews</a></li> <li><a href="/events/">Partner Events</a></li> <li><a href="/section/case-studies/">Case Studies</a></li> </ul> </nav> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>Opportunities</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/membership/">Membership</a></li> <li><a href="/advertising-media-kit/">Advertise</a></li> <li><a href="/m/editor-tool/">Submit Company</a></li> <li><a href="/contributor/">Write for Us</a></li> <li><a href="/guest-blog/guidelines/">Author Guidelines</a></li> <li><a href="/a/contact/">Contact Us</a></li> </ul> </nav> </div> </div> <hr> <div class="text-right">© BPT Analytics LTD 2024</div> </div></footer> <div id="bpt-consent"><div class="container"> <div class="row"> <div class="col-12 col-md-6 col-lg-8"> We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our <a href="/cookies-policy/">cookies policy</a>. </div> <div class="col-12 col-md-6 col-lg-4 text-right"> <button class="btn btn-primary btn-sm" type="button" onclick="changeConsent('analytics')" style="white-space:unset">Agree</button> </div> </div> </div></div> <div id="login-popup" class="hidden popup"> <div class="close" onclick="this.parentElement.classList.add('hidden')"><i class="glyphicon glyphicon-remove"></i></div> <div class="popup-content" style="width: 25em;"> <form method="post" class="api-form" action="/a/login/?next=/post/1020-schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery/"></form> </div> </div> <div id="subscription-popup" class="hidden popup"> <div class="close" onclick="this.parentElement.classList.add('hidden')"><i class="glyphicon glyphicon-remove"></i></div> <div id="subscription-popup-iframe" class="popup-content" style="width: 25em;"> </div> </div> <div id="scroll-top-pixel-anchor"></div> <button id="go-top" onclick="window.scrollTo({top: 20, left: 0, behavior: 'smooth'})">^</button> <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script> <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.4.1/js/bootstrap.min.js"></script> <script src="/static/js/main.df923d2272d3.js"></script> <script type="text/javascript"> if ( "IntersectionObserver" in window && "IntersectionObserverEntry" in window && "intersectionRatio" in window.IntersectionObserverEntry.prototype ) { let observer = new IntersectionObserver(entries => { if (entries[0].boundingClientRect.y < 0) { document.body.classList.add("scroll-top"); } else { document.body.classList.remove("scroll-top"); } }); observer.observe(document.getElementById("scroll-top-pixel-anchor")); } </script> </body> </html>